Close
Smartlab Europe
Inizio Ignite

News

Europe API Market To Grow At A CAGR of Over 5.5% Till 2033

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43 billion in 2023, and with an expected CAGR of 5.78% right from 2024 to 2033,...

Top Trends – Europe Active Pharmaceutical Ingredients Market

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but at the same time elaborate market for itself. The European market has been experiencing innumerable trends...

Discoveries In Chemical Synthesis Spurs New Developments

Austria’s University of Vienna’s team of chemists, which happen to be led by Nuno Maulide, has gone on to achieve quite a prominent breakthrough in terms of chemical synthesis through creating a novel method that manipulates carbon hydrogen bonds. This...

At ACHEMA, TekniPlex Healthcare to Demonstrate Automatic Filler-Sealer for Single-Dose Plastic Vials

Company will provide live demos of Pentafill® A25 Filling & Sealing Machine, which offers improved sterility and high output; TPHC also will showcase blister packaging solutions with sustainability offerings. TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver...

Singapore To Be Home To $1.5bn AstraZeneca Production Plant

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the company is looking to start the design and construction of the new Singapore setup by...

US Clinical Trials Supply & Logistics Market: A Growth Story

As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023 and, in another 10 years, will hit $3.95 billion, thereby growing at an impressive CAGR...

Advancements in Nitrosamine Detection and Control

Nitrosamines are unintended but potentially harmful impurities that can emerge during the manufacturing of pharmaceuticals. Recognized for their carcinogenic potential, the detection and control of these impurities are critical for ensuring drug safety. Recent advancements in analytical technologies have...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »